Panacea Index Logo

Command Palette

Search for a command to run...

A protein-enriched low glycemic index diet with omega-3 polyunsaturated fatty acid supplementation exerts beneficial effects on metabolic control in type 2 diabetes.

Primary care diabetes
December 1, 2014
Simone M Moosheer et al. (5 authors)
Clinical TrialJournal ArticleObservational StudyResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to investigate the practicability and effects of a protein-enriched, low-glycemic-index diet supplemented with omega-3 PUFA on metabolic control and inflammatory parameters in type 2 diabetes patients.

Results Summary

The dietary intervention significantly reduced HbA1c levels, waist circumference, and systemic inflammation (measured by usCRP) over 24 weeks in obese type 2 diabetes patients.

Population

Mostly obese patients with type 2 diabetes.

Effective Dosage

Not specified

Duration

24 weeks

Interactions

None mentioned

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
a combined dietary intervention with increased relative protein content supplemented with omega-3 polyunsaturated fatty acids (PUFA)
decrease
HbA1c
type 2 diabetes patients
from 63±11mmol/mol to 59±14mmol/mol after 12 weeks and 56±12mmol/mol after 24 weeks
significantly reduced
#1
a combined dietary intervention with increased relative protein content supplemented with omega-3 polyunsaturated fatty acids (PUFA)
decrease
usCRP
type 2 diabetes patients
-
decreased significantly
#2
a combined dietary intervention with increased relative protein content supplemented with omega-3 polyunsaturated fatty acids (PUFA)
decrease
waist circumference
type 2 diabetes patients
from 116.0±14.1cm to 114.9±13.5cm after 3 weeks, 114.0±14.4cm after 12 weeks, and 112.7±13.4cm after 24 weeks
decreased
#3
a protein enriched and low glycemic index diet supplemented with long-chain omega-3 PUFA
increase
glycemic control
overweight or obese patients with type 2 diabetes
-
improves
#4
a protein enriched and low glycemic index diet supplemented with long-chain omega-3 PUFA
decrease
waist circumference
overweight or obese patients with type 2 diabetes
-
reduces
#5
a protein enriched and low glycemic index diet supplemented with long-chain omega-3 PUFA
decrease
silent inflammation
overweight or obese patients with type 2 diabetes
-
reduces
#6
Abstract

AIMS: The current study aims to investigate practicability and effects of a combined dietary intervention with increased relative protein content supplemented with omega-3 polyunsaturated fatty acids (PUFA) on metabolic control and inflammatory parameters in a real life situation in type 2 diabetes patients. METHODS: In this observational study we advised thirty mostly obese patients with type 2 diabetes to follow a protein-enriched diet with carbohydrates of low glycemic index (low GI) and moderate fat reduction supplemented with omega-3 PUFA for 24 weeks. Primary efficacy parameter was the change in HbA1c; secondary parameters included changes in systemic inflammation (measured by ultrasensitive C-reactive protein, usCRP), body weight, waist circumference, fat mass. The study is registered at clinicaltrials.gov (NCT01474603). RESULTS: The dietary intervention significantly reduced the primary efficacy variable HbA1c from a baseline value of 63±11mmol/mol to 59±14mmol/mol (P=0.033) and 56±12mmol/mol (P=0.001) after 12 and 24 weeks, respectively. In addition, usCRP decreased significantly at 24 weeks (P=0.039). Waist circumference, an important indicator for cardiometabolic-risk and silent inflammation, decreased from baseline 116.0±14.1cm to 114.9±13.5cm (P=0.019), 114.0±14.4cm (P=0.001), and 112.7±13.4cm (P=0.049), after 3, 12 and 24 weeks, respectively. CONCLUSION: Counseling a protein enriched and low glycemic index diet supplemented with long-chain omega-3 PUFA in a real-life clinical setting improves glycemic control and also reduces waist circumference and silent inflammation in overweight or obese patients with type 2 diabetes.

Medical Subject Headings (MeSH)
AdiposityAdultAgedAustriaBiomarkersBody Mass IndexC-Reactive ProteinDiabetes Mellitus, Type 2Diet, Fat-RestrictedDietary CarbohydratesDietary ProteinsDietary SupplementsEnergy MetabolismFatty Acids, Omega-3FemaleGlycated HemoglobinGlycemic IndexHumansInflammation MediatorsMaleMiddle AgedObesityPilot ProjectsTime FactorsTreatment OutcomeWaist CircumferenceWeight Loss
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality75/10
Citation Metrics
Total Citations15
Citations/Year1.4
Relative Citation Ratio0.65
NIH Percentile35%
Research Impact Scores
APT Score0.75
Weight Score1.53
Normalized Score0.69
Related Supplements